Incyte Corporation

Healthcare · Biotechnology · United States

Last price 120.39 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 24.54B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI for the treatment of myelofibrosis (MF), polycythemia vera, and steroid-refractory acute graft-versus-host disease; ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; MONJUVI/MINJUVI for the treatment of diffuse large B-cell lymphoma and Follicular Lymphoma; NIKTIMVO for...